Trials / Terminated
TerminatedNCT02703454
FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
Focal Impulse and Rotor Modulation (FIRM) Ablation Versus Pulmonary Vein Isolation (PVI) for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed as a prospective, multicenter, single-blind, randomized study to assess the safety and effectiveness of FIRM-guided radiofrequency (RF) ablation procedures for the treatment of symptomatic paroxysmal atrial fibrillation (PAF). The subjects will be blinded to study treatment for the duration of the study period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | FIRM-guided RF ablation | |
| PROCEDURE | Conventional RF ablation |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2018-02-01
- Completion
- 2018-02-01
- First posted
- 2016-03-09
- Last updated
- 2019-05-21
- Results posted
- 2019-05-21
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02703454. Inclusion in this directory is not an endorsement.